Skip to main content

Table 1 Specific COX-2 inhibitors in patients with aspirin-exacerbated respiratory disorders (aspirin-induced asthma)

From: COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease

Study COX-2 inhibitor Number of patients Adverse reaction* Aspirin response
Woessner et al. [3] Celecoxib 60 No Yes
Dahlen et al. [9] Celecoxib 27 No Not tested
Szczeklik et al. [8] Rofecoxib 12 No Yes
Stevenson et al. [10] Rofecoxib 60 No Yes
  1. * Decrease in FEV1 (forced expiratory volume in 1 s) and/or induced naso-ocular symptoms.